Lifeward Ltd. LFWD

Company Overview

Lifeward Ltd. is a medical technology company focused on developing and commercializing wearable robotics and rehabilitation technologies designed to improve mobility and quality of life for individuals with physical disabilities and neurological conditions. The company operates primarily within the medical devices, rehabilitation technology, and assistive robotics industries. Lifeward is best known for its FDA-cleared robotic exoskeleton systems used in rehabilitation settings and for personal mobility assistance, particularly for individuals with spinal cord injuries.

The company’s primary revenue drivers include sales and leasing of its robotic exoskeleton systems, rehabilitation products, and related service and support offerings. Its flagship products include the ReWalk Personal Exoskeleton, ReWalk Rehabilitation Exoskeleton, and the AlterG anti-gravity rehabilitation treadmill systems acquired through the purchase of AlterG, Inc. Lifeward serves rehabilitation clinics, hospitals, veterans’ healthcare systems, and individual patients across several international markets. The company was originally founded as ReWalk Robotics Ltd. in Israel and later rebranded to Lifeward in 2023 to reflect a broader rehabilitation and mobility technology strategy beyond exoskeletons alone.

Business Operations

Lifeward conducts operations through mobility and rehabilitation technology businesses centered on wearable robotics and therapeutic rehabilitation equipment. Its principal operating activities include development, manufacturing, marketing, and servicing of robotic exoskeletons and rehabilitation systems. The company generates revenue from direct product sales, distributor relationships, clinical rehabilitation placements, recurring service agreements, and reimbursement-supported patient access programs. The company’s core business units include the ReWalk exoskeleton platform and the AlterG rehabilitation treadmill business.

The company operates in both domestic and international markets, with significant activity in the United States, Europe, and parts of the Asia-Pacific region. Lifeward maintains proprietary robotic mobility technologies, motion-control software, and rehabilitation engineering capabilities. The company has worked with rehabilitation hospitals, veterans’ organizations, and healthcare providers to expand patient access and reimbursement pathways. Public filings and corporate disclosures also identify relationships with distributors and clinical partners supporting commercialization efforts outside direct sales regions.

Strategic Position & Investments

Lifeward’s strategic direction centers on expanding access to rehabilitation and mobility technologies while broadening its portfolio across neurological recovery and physical rehabilitation markets. The acquisition of AlterG, Inc. significantly expanded the company’s rehabilitation footprint by adding anti-gravity treadmill systems widely used in sports medicine, neurological rehabilitation, and orthopedic recovery. Management has emphasized increasing recurring revenue opportunities, improving reimbursement coverage, and expanding clinical adoption of rehabilitation technologies.

The company has invested in product development aimed at improving usability, accessibility, and integration into rehabilitation workflows. Lifeward has also pursued growth through partnerships with rehabilitation centers, healthcare systems, and payer organizations. Emerging focus areas include robotic-assisted rehabilitation, gait training technologies, and broader neurorehabilitation applications. Public company disclosures indicate continued efforts to improve commercial scalability while navigating reimbursement, regulatory, and adoption challenges common within advanced medical device markets.

Geographic Footprint

Lifeward is headquartered in Marlborough, Massachusetts, with historical operational roots in Israel. The company maintains a global commercial presence spanning North America, Europe, and selected markets in Asia-Pacific. The United States represents its largest commercial market, particularly through rehabilitation centers, veterans’ healthcare programs, and medical institutions adopting robotic mobility technologies.

Internationally, Lifeward has utilized distributor networks and direct commercial operations to support product deployment across multiple countries. The company’s technologies have been used in rehabilitation clinics and healthcare systems throughout Germany, the United Kingdom, and other European markets where exoskeleton and rehabilitation technologies have gained regulatory acceptance. Its international operations remain influenced by regional reimbursement policies, regulatory approvals, and healthcare infrastructure adoption trends.

Leadership & Governance

Lifeward’s leadership team combines experience in medical devices, rehabilitation technologies, robotics, and healthcare commercialization. The company transitioned from its earlier identity as ReWalk Robotics as part of a broader strategic repositioning effort intended to support long-term expansion beyond wearable exoskeleton systems. Corporate governance and reporting obligations are governed through its status as a publicly traded company listed on Nasdaq under the ticker LFWD.

Key executives include:

• Larry Jasinski – Chief Executive Officer
• Mike Lawless – Chief Financial Officer
• Brian Rezner – Chief Operating Officer
• Mandi Pratt-Chapman – Member of the Board of Directors
• Yair Goffer – Founder and Director

Leadership has consistently communicated a strategy focused on improving patient mobility outcomes, expanding reimbursement access, increasing rehabilitation adoption, and integrating advanced robotics into mainstream rehabilitative care. Statements regarding strategic priorities and operational direction are reflected in company investor materials, earnings communications, and SEC filings, including annual reports on Form 10-K and quarterly reports on Form 10-Q.